Showing results (341-350 of 623) with videos related to
Sort By:
Pageof 63
EJNMMI Physics|June 15, 2026
Limitations in diagnostics and quantification of small lesions with low uptake in the clinical context of prostate 18F/68Ga-PSMA PET/MRIMaike E Lindemann, Walter Jentzen, Alina Küper, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2010
Phenotyping of tumor biology in patients by multimodality multiparametric imaging: relationship of microcirculation, alphavbeta3 expression, and glucose metabolismStephan Metz, Carl Ganter, Sylvie Lorenzen, et al.Nuklearmedizin. Nuclear Medicine|March 17, 2022
Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear MedicineMatthias Schmidt, Peter Bartenstein, Jan Bucerius, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 12, 2020
Identification of PCWG3 Target Populations Is More Accurate and Reproducible with PSMA PET Than with Conventional Imaging: A Multicenter Retrospective StudyAndrea Farolfi, Nader Hirmas, Andrei Gafita, et al.European Journal of Nuclear Medicine and Molecular Imaging|July 29, 2022
Artificial intelligence guided enhancement of digital PET: scans as fast as CT?René Hosch, Manuel Weber, Miriam Sraieb, et al.European Radiology|June 20, 2023
[18F]FDG PET/MRI in children suffering from lymphoma: does MRI contrast media make a difference?Kai Jannusch, Janna Morawitz, Bernd Schweiger, et al.Cancer|December 13, 2012
(18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcomaAkram Al-Ibraheem, Andreas K Buck, Matthias R Benz, et al.European Radiology|December 1, 2023
Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRIKai Jannusch, Nils Martin Bruckmann, Janna Morawitz, et al.Clinical Nuclear Medicine|October 26, 2023
PSMA Radioligand Therapy in Prostate Cancer: Where Are We and Where Are We Heading?Ludmila Santiago Almeida, Elba Cristina Sá de Camargo Etchebehere, Irene García Megías, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 28, 2015
PET response criteria in solid tumors predicts progression-free survival and time to local or distant progression after chemotherapy with regional hyperthermia for soft-tissue sarcomaWolfgang P Fendler, Mona Lehmann, Andrei Todica, et al.Pageof 63